H&F weighs $9 billion-plus sale of medical device maker Cordis: Report

U.S. private equity firm Hellman & Friedman is in early-stage talks for ‌a ‌potential sale of medical devices maker ‌Cordis, seeking a value of over $9 billion, Bloomberg News reported on Friday, citing people familiar with the matter.

About half a dozen publicly traded medical ‌device ‍companies are currently evaluating ‍potential bids for Cordis, the ‌report added.

Hellman & Friedman bought Cordis from Cardinal Health in 2021 for about $1 billion, six years after Johnson & Johnson sold it.


Cordis is known ‍for making cardiovascular devices such as catheters and ‍stents.

H&F declined ⁠to ⁠comment. Cordis and one of its investors KKR did not immediately respond to Reuters' requests for comment outside of regular business hours.